2021
|
|

Abstract: Background and Objectives Iron overload in thalassaemia is a crucial prognostic factor and a major cause of death due to heart failure or arrhythmia. Therefore, previous research has recommended amlodipine as an auxiliary treatment to current chelating agents for reducing iron overload in thalassaemia patients. Materials and Methods A systematic review and meta‐analysis of the results of three randomized clinical trials evaluating the use of amlodipine in thalassaemia patients through 12 databases were carried… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
2
0

Publication Types

Select...

Relationship

0
0

Authors

Journals